Dr. Zhiyong Li, MD
What this data tells you about Dr. Li
Dr. Zhiyong Li is a hematology & oncology in Garland, TX, with 19 years in practice. Based on federal Medicare data, Dr. Li performed 22,102 Medicare services across 1,233 unique beneficiaries.
Between the years covered by Open Payments, Dr. Li received a total of $10,387 from 71 pharmaceutical and/or device companies across 496 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Li is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia | 9,720 | $6 | $28 |
| Dexamethasone injection (steroid) | 2,532 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,341 | $1 | $65 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,064 | $23 | $135 |
| Office visit, established patient (30-39 min) | 1,048 | $99 | $194 |
| Injection, granisetron hydrochloride, 100 mcg | 1,031 | $0 | $45 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 875 | $1 | $30 |
| Blood draw (venipuncture) | 621 | $8 | $20 |
| Hospital follow-up visit, high complexity | 616 | $94 | $185 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 612 | $74 | $710 |
| Drug injection, under skin or into muscle | 318 | $11 | $65 |
| Unclassified drugs | 316 | $1 | $10 |
| Injection, diphenhydramine hcl, up to 50 mg | 305 | $1 | $10 |
| Administration of chemotherapy into vein, 1 hour or less | 246 | $105 | $435 |
| Administration of chemotherapy into vein, each additional hour | 243 | $23 | $100 |
| Critical care, first 30-74 min | 201 | $167 | $500 |
| Initial hospital admission, high complexity | 146 | $136 | $400 |
| Injection, heparin sodium, per 1000 units | 123 | $0 | $5 |
| Administration of additional new drug or substance into vein, 1 hour or less | 122 | $52 | $200 |
| Injection of additional new drug or substance into vein | 121 | $12 | $75 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 118 | $51 | $250 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 113 | $16 | $150 |
| Office visit, established patient, complex (40-54 min) | 106 | $141 | $284 |
| New patient office visit, complex (60-74 min) | 47 | $169 | $500 |
| Office visit, established patient (20-29 min) | 40 | $72 | $125 |
| Influenza vaccine, quadrivalent derived from cell cultures | 39 | $32 | $50 |
| Flu vaccine administration | 38 | $29 | $32 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Li is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Li experienced with epoetin alfa injection (procrit) for anemia?
Does Dr. Li receive payments from pharmaceutical companies?
How do Dr. Li's costs compare to other hematology & oncologys in Garland?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology